Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-041907
Filing Date
2009-03-02
Accepted
2009-03-02 09:39:43
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA INCORPORATED - FORM 10-K d10k.htm 10-K 1265648
2 FORM OF CHANGE OF CONTROL AGREEMENT dex109.htm EX-10.9 53105
3 VIROPHARMA BOARD COMPENSATION POLICY dex1019.htm EX-10.19 2301
4 LIST OF SUBSIDIARIES dex21.htm EX-21 2885
5 CONSENT OF KPMG LLP dex23.htm EX-23 2767
6 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 9287
7 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 9316
8 SECTION 906 CERTIFICATION OF CEO AND CFO dex321.htm EX-32.1 3999
  Complete submission text file 0001193125-09-041907.txt   1350678
Mailing Address 397 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 397 EAGLEVIEW BLVD EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 09645557
SIC: 2834 Pharmaceutical Preparations